Review



u 2 os osteosarcoma human cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC u 2 os osteosarcoma human cells
    Microfluidic electroporation validation using U2 OS cells and YO-PRO™-1. (A) Photograph of assembled custom microfluidic electroporation chamber. The chamber comprises a pair of aluminum electrodes 20 mm in length and spaced 1 mm apart. The coverslip glass measures 50 mm by 25 mm and can be fitted to standard microscope stages and environmental chambers. The microfluidic channel holds approximately 2.5 µL of cell resuspended cell culture. The channel was mounted on cover slip glass, allowing for higher resolution microscopy. (B) & (C) Composite fluorescence micrographs of <t>adherent</t> <t>U-2</t> OS cells within the microfluidic electroporation chamber in the presence of YO-PRO™-1 before and after electroporation, respectively. Scale = 50 µm.
    U 2 Os Osteosarcoma Human Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 8853 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/u 2 os osteosarcoma human cells/product/ATCC
    Average 99 stars, based on 8853 article reviews
    u 2 os osteosarcoma human cells - by Bioz Stars, 2026-02
    99/100 stars

    Images

    1) Product Images from "OpenPore: A low-cost, portable, battery-powered exponential decay pulse generator for electroporation"

    Article Title: OpenPore: A low-cost, portable, battery-powered exponential decay pulse generator for electroporation

    Journal: HardwareX

    doi: 10.1016/j.ohx.2025.e00730

    Microfluidic electroporation validation using U2 OS cells and YO-PRO™-1. (A) Photograph of assembled custom microfluidic electroporation chamber. The chamber comprises a pair of aluminum electrodes 20 mm in length and spaced 1 mm apart. The coverslip glass measures 50 mm by 25 mm and can be fitted to standard microscope stages and environmental chambers. The microfluidic channel holds approximately 2.5 µL of cell resuspended cell culture. The channel was mounted on cover slip glass, allowing for higher resolution microscopy. (B) & (C) Composite fluorescence micrographs of adherent U-2 OS cells within the microfluidic electroporation chamber in the presence of YO-PRO™-1 before and after electroporation, respectively. Scale = 50 µm.
    Figure Legend Snippet: Microfluidic electroporation validation using U2 OS cells and YO-PRO™-1. (A) Photograph of assembled custom microfluidic electroporation chamber. The chamber comprises a pair of aluminum electrodes 20 mm in length and spaced 1 mm apart. The coverslip glass measures 50 mm by 25 mm and can be fitted to standard microscope stages and environmental chambers. The microfluidic channel holds approximately 2.5 µL of cell resuspended cell culture. The channel was mounted on cover slip glass, allowing for higher resolution microscopy. (B) & (C) Composite fluorescence micrographs of adherent U-2 OS cells within the microfluidic electroporation chamber in the presence of YO-PRO™-1 before and after electroporation, respectively. Scale = 50 µm.

    Techniques Used: Electroporation, Biomarker Discovery, Microscopy, Cell Culture, Fluorescence



    Similar Products

    99
    ATCC u 2 os osteosarcoma human cells
    Microfluidic electroporation validation using U2 OS cells and YO-PRO™-1. (A) Photograph of assembled custom microfluidic electroporation chamber. The chamber comprises a pair of aluminum electrodes 20 mm in length and spaced 1 mm apart. The coverslip glass measures 50 mm by 25 mm and can be fitted to standard microscope stages and environmental chambers. The microfluidic channel holds approximately 2.5 µL of cell resuspended cell culture. The channel was mounted on cover slip glass, allowing for higher resolution microscopy. (B) & (C) Composite fluorescence micrographs of <t>adherent</t> <t>U-2</t> OS cells within the microfluidic electroporation chamber in the presence of YO-PRO™-1 before and after electroporation, respectively. Scale = 50 µm.
    U 2 Os Osteosarcoma Human Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/u 2 os osteosarcoma human cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    u 2 os osteosarcoma human cells - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    ATCC human osteosarcoma u2os cells
    Microfluidic electroporation validation using U2 OS cells and YO-PRO™-1. (A) Photograph of assembled custom microfluidic electroporation chamber. The chamber comprises a pair of aluminum electrodes 20 mm in length and spaced 1 mm apart. The coverslip glass measures 50 mm by 25 mm and can be fitted to standard microscope stages and environmental chambers. The microfluidic channel holds approximately 2.5 µL of cell resuspended cell culture. The channel was mounted on cover slip glass, allowing for higher resolution microscopy. (B) & (C) Composite fluorescence micrographs of <t>adherent</t> <t>U-2</t> OS cells within the microfluidic electroporation chamber in the presence of YO-PRO™-1 before and after electroporation, respectively. Scale = 50 µm.
    Human Osteosarcoma U2os Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human osteosarcoma u2os cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    human osteosarcoma u2os cells - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    ATCC human osteosarcoma mg63 cell line
    Microfluidic electroporation validation using U2 OS cells and YO-PRO™-1. (A) Photograph of assembled custom microfluidic electroporation chamber. The chamber comprises a pair of aluminum electrodes 20 mm in length and spaced 1 mm apart. The coverslip glass measures 50 mm by 25 mm and can be fitted to standard microscope stages and environmental chambers. The microfluidic channel holds approximately 2.5 µL of cell resuspended cell culture. The channel was mounted on cover slip glass, allowing for higher resolution microscopy. (B) & (C) Composite fluorescence micrographs of <t>adherent</t> <t>U-2</t> OS cells within the microfluidic electroporation chamber in the presence of YO-PRO™-1 before and after electroporation, respectively. Scale = 50 µm.
    Human Osteosarcoma Mg63 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human osteosarcoma mg63 cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    human osteosarcoma mg63 cell line - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    ATCC human osteosarcoma cell line u2os
    (A) MTORC1 and AMPK activity is influenced by amino acids and glucose, respectively, and regulate ULK1 activity, which induces autophagy. (B-E) <t>U2OS</t> cells were treated with full media (FM), FM lacking glucose (-Glc), or FM lacking amino acids (-aa) for the indicated times and cell lysates analyzed by immunoblot for ACC, total and phosphorylated at S79 (B, D) , and S6K1 phosphorylated at T389 and actin as a loading control (C, E) . Immunoblots were quantified and signal normalized to total ACC (for D) or actin loading control (for E) plotted. Symbols represent mean of 3 independent experiments and bars are s.e.m. (F-I) Monoclonal U2OS cell lines expressing DFCP1 (F) , WIPI2B (G) , WIPI1 (H) , or ATG5 ( I ) were treated with FM (blue), -Glc (green), or -aa media (red) for 6 hours and subjected to live-cell fluorescent imaging. GFP-puncta (objects) for each reporter were quantified from single cells. Trajectories include mean objects per cell (symbols); bars represent 95% CI. (J-K) GFP-LC3B objects were quantified from cells treated with FM, -aa, or -Glc in the presence of BafA1 (to prevent lysosome degradation) or a vehicle control in 2 hour increments (J) . The number of GFP-LC3 puncta synthesized (solid symbols) and degraded (open symbols) from time 0 min was calculated and plotted. The dashed lines demarcate where individual datasets were collected and data stitched together. Trajectories include mean puncta per cell (symbols); bars represent standard deviation.
    Human Osteosarcoma Cell Line U2os, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human osteosarcoma cell line u2os/product/ATCC
    Average 99 stars, based on 1 article reviews
    human osteosarcoma cell line u2os - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    ATCC human osteosarcoma cell lines
    Acetylshikonin reduces <t>osteosarcoma</t> cell viability and increases membrane permeability. (A) Molecular structure of acetylshikonin. (B) CCK-8 assay results showing the viability of hFOB 1.19 cells following exposure to acetylshikonin (0.5–3 µM) for 24 h (n=4). (C) <t>MG63,</t> (D) HOS and (E) <t>U2OS</t> cell viability was assessed using the CCK-8 assay following treatment with acetylshikonin (0.05–20 µM) for 24 and 48 h (n=4). (F) Phase-contrast microscopy images depicting morphological changes in osteosarcoma cells treated with acetylshikonin (3 µM) for 24 h (n=4). (G) Fluorescence microscopy images showing nuclear staining with Hoechst 33342, membrane integrity with PI and viability with Calcein-AM in osteosarcoma cells treated with acetylshikonin (0.5–10 µM) for 24 h (n=4). Data are presented as the mean ± SD. *P<0.05 vs. untreated control. CCK-8, Cell Counting Kit-8; PI, propidium iodide.
    Human Osteosarcoma Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human osteosarcoma cell lines/product/ATCC
    Average 99 stars, based on 1 article reviews
    human osteosarcoma cell lines - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    ATCC 143b human osteosarcoma cell line
    Acetylshikonin reduces <t>osteosarcoma</t> cell viability and increases membrane permeability. (A) Molecular structure of acetylshikonin. (B) CCK-8 assay results showing the viability of hFOB 1.19 cells following exposure to acetylshikonin (0.5–3 µM) for 24 h (n=4). (C) <t>MG63,</t> (D) HOS and (E) <t>U2OS</t> cell viability was assessed using the CCK-8 assay following treatment with acetylshikonin (0.05–20 µM) for 24 and 48 h (n=4). (F) Phase-contrast microscopy images depicting morphological changes in osteosarcoma cells treated with acetylshikonin (3 µM) for 24 h (n=4). (G) Fluorescence microscopy images showing nuclear staining with Hoechst 33342, membrane integrity with PI and viability with Calcein-AM in osteosarcoma cells treated with acetylshikonin (0.5–10 µM) for 24 h (n=4). Data are presented as the mean ± SD. *P<0.05 vs. untreated control. CCK-8, Cell Counting Kit-8; PI, propidium iodide.
    143b Human Osteosarcoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/143b human osteosarcoma cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    143b human osteosarcoma cell line - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    ATCC human osteosarcoma os cell lines mg 63
    Acetylshikonin reduces <t>osteosarcoma</t> cell viability and increases membrane permeability. (A) Molecular structure of acetylshikonin. (B) CCK-8 assay results showing the viability of hFOB 1.19 cells following exposure to acetylshikonin (0.5–3 µM) for 24 h (n=4). (C) <t>MG63,</t> (D) HOS and (E) <t>U2OS</t> cell viability was assessed using the CCK-8 assay following treatment with acetylshikonin (0.05–20 µM) for 24 and 48 h (n=4). (F) Phase-contrast microscopy images depicting morphological changes in osteosarcoma cells treated with acetylshikonin (3 µM) for 24 h (n=4). (G) Fluorescence microscopy images showing nuclear staining with Hoechst 33342, membrane integrity with PI and viability with Calcein-AM in osteosarcoma cells treated with acetylshikonin (0.5–10 µM) for 24 h (n=4). Data are presented as the mean ± SD. *P<0.05 vs. untreated control. CCK-8, Cell Counting Kit-8; PI, propidium iodide.
    Human Osteosarcoma Os Cell Lines Mg 63, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human osteosarcoma os cell lines mg 63/product/ATCC
    Average 99 stars, based on 1 article reviews
    human osteosarcoma os cell lines mg 63 - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    97
    ATCC human bone osteosarcoma epithelial cells
    Acetylshikonin reduces <t>osteosarcoma</t> cell viability and increases membrane permeability. (A) Molecular structure of acetylshikonin. (B) CCK-8 assay results showing the viability of hFOB 1.19 cells following exposure to acetylshikonin (0.5–3 µM) for 24 h (n=4). (C) <t>MG63,</t> (D) HOS and (E) <t>U2OS</t> cell viability was assessed using the CCK-8 assay following treatment with acetylshikonin (0.05–20 µM) for 24 and 48 h (n=4). (F) Phase-contrast microscopy images depicting morphological changes in osteosarcoma cells treated with acetylshikonin (3 µM) for 24 h (n=4). (G) Fluorescence microscopy images showing nuclear staining with Hoechst 33342, membrane integrity with PI and viability with Calcein-AM in osteosarcoma cells treated with acetylshikonin (0.5–10 µM) for 24 h (n=4). Data are presented as the mean ± SD. *P<0.05 vs. untreated control. CCK-8, Cell Counting Kit-8; PI, propidium iodide.
    Human Bone Osteosarcoma Epithelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bone osteosarcoma epithelial cells/product/ATCC
    Average 97 stars, based on 1 article reviews
    human bone osteosarcoma epithelial cells - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    99
    ATCC human u2os osteosarcoma cell line
    Acetylshikonin reduces <t>osteosarcoma</t> cell viability and increases membrane permeability. (A) Molecular structure of acetylshikonin. (B) CCK-8 assay results showing the viability of hFOB 1.19 cells following exposure to acetylshikonin (0.5–3 µM) for 24 h (n=4). (C) <t>MG63,</t> (D) HOS and (E) <t>U2OS</t> cell viability was assessed using the CCK-8 assay following treatment with acetylshikonin (0.05–20 µM) for 24 and 48 h (n=4). (F) Phase-contrast microscopy images depicting morphological changes in osteosarcoma cells treated with acetylshikonin (3 µM) for 24 h (n=4). (G) Fluorescence microscopy images showing nuclear staining with Hoechst 33342, membrane integrity with PI and viability with Calcein-AM in osteosarcoma cells treated with acetylshikonin (0.5–10 µM) for 24 h (n=4). Data are presented as the mean ± SD. *P<0.05 vs. untreated control. CCK-8, Cell Counting Kit-8; PI, propidium iodide.
    Human U2os Osteosarcoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human u2os osteosarcoma cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    human u2os osteosarcoma cell line - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    Image Search Results


    Microfluidic electroporation validation using U2 OS cells and YO-PRO™-1. (A) Photograph of assembled custom microfluidic electroporation chamber. The chamber comprises a pair of aluminum electrodes 20 mm in length and spaced 1 mm apart. The coverslip glass measures 50 mm by 25 mm and can be fitted to standard microscope stages and environmental chambers. The microfluidic channel holds approximately 2.5 µL of cell resuspended cell culture. The channel was mounted on cover slip glass, allowing for higher resolution microscopy. (B) & (C) Composite fluorescence micrographs of adherent U-2 OS cells within the microfluidic electroporation chamber in the presence of YO-PRO™-1 before and after electroporation, respectively. Scale = 50 µm.

    Journal: HardwareX

    Article Title: OpenPore: A low-cost, portable, battery-powered exponential decay pulse generator for electroporation

    doi: 10.1016/j.ohx.2025.e00730

    Figure Lengend Snippet: Microfluidic electroporation validation using U2 OS cells and YO-PRO™-1. (A) Photograph of assembled custom microfluidic electroporation chamber. The chamber comprises a pair of aluminum electrodes 20 mm in length and spaced 1 mm apart. The coverslip glass measures 50 mm by 25 mm and can be fitted to standard microscope stages and environmental chambers. The microfluidic channel holds approximately 2.5 µL of cell resuspended cell culture. The channel was mounted on cover slip glass, allowing for higher resolution microscopy. (B) & (C) Composite fluorescence micrographs of adherent U-2 OS cells within the microfluidic electroporation chamber in the presence of YO-PRO™-1 before and after electroporation, respectively. Scale = 50 µm.

    Article Snippet: U-2 OS osteosarcoma human cells (ATCC) were used and resuspended at approximately 6 × 10 6 cells/mL in DMEM – High Glucose (Gibco).

    Techniques: Electroporation, Biomarker Discovery, Microscopy, Cell Culture, Fluorescence

    (A) MTORC1 and AMPK activity is influenced by amino acids and glucose, respectively, and regulate ULK1 activity, which induces autophagy. (B-E) U2OS cells were treated with full media (FM), FM lacking glucose (-Glc), or FM lacking amino acids (-aa) for the indicated times and cell lysates analyzed by immunoblot for ACC, total and phosphorylated at S79 (B, D) , and S6K1 phosphorylated at T389 and actin as a loading control (C, E) . Immunoblots were quantified and signal normalized to total ACC (for D) or actin loading control (for E) plotted. Symbols represent mean of 3 independent experiments and bars are s.e.m. (F-I) Monoclonal U2OS cell lines expressing DFCP1 (F) , WIPI2B (G) , WIPI1 (H) , or ATG5 ( I ) were treated with FM (blue), -Glc (green), or -aa media (red) for 6 hours and subjected to live-cell fluorescent imaging. GFP-puncta (objects) for each reporter were quantified from single cells. Trajectories include mean objects per cell (symbols); bars represent 95% CI. (J-K) GFP-LC3B objects were quantified from cells treated with FM, -aa, or -Glc in the presence of BafA1 (to prevent lysosome degradation) or a vehicle control in 2 hour increments (J) . The number of GFP-LC3 puncta synthesized (solid symbols) and degraded (open symbols) from time 0 min was calculated and plotted. The dashed lines demarcate where individual datasets were collected and data stitched together. Trajectories include mean puncta per cell (symbols); bars represent standard deviation.

    Journal: PLOS One

    Article Title: Quantitative and temporal analysis of autophagy: Differential Response to amino acid and glucose starvation

    doi: 10.1371/journal.pone.0340957

    Figure Lengend Snippet: (A) MTORC1 and AMPK activity is influenced by amino acids and glucose, respectively, and regulate ULK1 activity, which induces autophagy. (B-E) U2OS cells were treated with full media (FM), FM lacking glucose (-Glc), or FM lacking amino acids (-aa) for the indicated times and cell lysates analyzed by immunoblot for ACC, total and phosphorylated at S79 (B, D) , and S6K1 phosphorylated at T389 and actin as a loading control (C, E) . Immunoblots were quantified and signal normalized to total ACC (for D) or actin loading control (for E) plotted. Symbols represent mean of 3 independent experiments and bars are s.e.m. (F-I) Monoclonal U2OS cell lines expressing DFCP1 (F) , WIPI2B (G) , WIPI1 (H) , or ATG5 ( I ) were treated with FM (blue), -Glc (green), or -aa media (red) for 6 hours and subjected to live-cell fluorescent imaging. GFP-puncta (objects) for each reporter were quantified from single cells. Trajectories include mean objects per cell (symbols); bars represent 95% CI. (J-K) GFP-LC3B objects were quantified from cells treated with FM, -aa, or -Glc in the presence of BafA1 (to prevent lysosome degradation) or a vehicle control in 2 hour increments (J) . The number of GFP-LC3 puncta synthesized (solid symbols) and degraded (open symbols) from time 0 min was calculated and plotted. The dashed lines demarcate where individual datasets were collected and data stitched together. Trajectories include mean puncta per cell (symbols); bars represent standard deviation.

    Article Snippet: The human osteosarcoma cell line U2OS (HTB-96) was purchased from American Type Culture Collection, and cells maintained in RPMI-1640 medium (Gibco, 11-875-119) supplemented with 10% fetal bovine serum (Corning, 35–010-CV) and cultured at 37°C in a humidified atmosphere containing 5% CO 2 .

    Techniques: Activity Assay, Western Blot, Control, Expressing, Imaging, Synthesized, Standard Deviation

    (A-B) U2OS cells were treated for 6 hours with FM (blue), indicated as 100% aa (the concentration found in RPMI-1640), or 10% (green), 5% (orange), or 0% (red) of that amino acid concentration. Cells were lysed and ULK1 phosphorylated at S758 quantified (relative to actin loading control and normalized to time 0 controls) (A) . Bars represent means of 3 biological replicates. The data in (A) was fit to a sigmoidal dose-response curve (dashed line) to generate an EC 50 of 6% aa (B) . (C-D) Cells were treated with the medias described in A and imaged live from hours 4-6 in the presence of BafA1 (as in ). GFP-LC3 puncta were quantified from cells and sum intensity plotted (this is the sum of the intensity of all GFP-positive pixels, an output used to avoid potential issues with aggregated vesicles). Trajectories include mean objects per cell (symbols); bars represent s.e.m.; black lines represent simple linear regression (C) . The GFP-LC3 synthesis rates from the linear regression lines in (C) across amino acid concentrations were fit to a sigmoidal dose-response curve (dashed line) to generate an EC 50 of 7% aa (D) . (E) The rate of GFP-LC3 synthesis (derived from linear regression analysis, shown in (C) and the relative level of pULK1-S758 (from A) plotted to show a negative, linear association (dashed line, r 2 = 0.815).

    Journal: PLOS One

    Article Title: Quantitative and temporal analysis of autophagy: Differential Response to amino acid and glucose starvation

    doi: 10.1371/journal.pone.0340957

    Figure Lengend Snippet: (A-B) U2OS cells were treated for 6 hours with FM (blue), indicated as 100% aa (the concentration found in RPMI-1640), or 10% (green), 5% (orange), or 0% (red) of that amino acid concentration. Cells were lysed and ULK1 phosphorylated at S758 quantified (relative to actin loading control and normalized to time 0 controls) (A) . Bars represent means of 3 biological replicates. The data in (A) was fit to a sigmoidal dose-response curve (dashed line) to generate an EC 50 of 6% aa (B) . (C-D) Cells were treated with the medias described in A and imaged live from hours 4-6 in the presence of BafA1 (as in ). GFP-LC3 puncta were quantified from cells and sum intensity plotted (this is the sum of the intensity of all GFP-positive pixels, an output used to avoid potential issues with aggregated vesicles). Trajectories include mean objects per cell (symbols); bars represent s.e.m.; black lines represent simple linear regression (C) . The GFP-LC3 synthesis rates from the linear regression lines in (C) across amino acid concentrations were fit to a sigmoidal dose-response curve (dashed line) to generate an EC 50 of 7% aa (D) . (E) The rate of GFP-LC3 synthesis (derived from linear regression analysis, shown in (C) and the relative level of pULK1-S758 (from A) plotted to show a negative, linear association (dashed line, r 2 = 0.815).

    Article Snippet: The human osteosarcoma cell line U2OS (HTB-96) was purchased from American Type Culture Collection, and cells maintained in RPMI-1640 medium (Gibco, 11-875-119) supplemented with 10% fetal bovine serum (Corning, 35–010-CV) and cultured at 37°C in a humidified atmosphere containing 5% CO 2 .

    Techniques: Concentration Assay, Control, Derivative Assay

    (A) GFP-WIPI1 (green, left Y-axis) and GFP-WIPI2B (purple, right Y-axis) object counts over the 6 hour -aa treatment were overlaid. The gray region indicates the immediate starvation period (0-1 hours), and the yellow highlights the period of delayed autophagy under sustained starvation (3-6 hours). (B) EGFP-2xFYVE puncta (PI(3)P-positive cell membranes) were quantified from cells under FM (blue) or -aa (red) treatment. Note a lack of substantial puncta increase in the immediate (0-1 hour) period (gray shading). (C) The fraction of cells containing at least 1 GFP-WIPI2B puncta is plotted with time of -aa starvation. The dashed line represents 50% of the cell population. (D) Representative EGFP-2xFYVE puncta in U2OS cells treated with a VPS34 inhibitor (1 μM compound 31, lower panels) or vehicle control (upper panels). Blue = Hoechst nuclear stain; green = EGFP-2xFYVE; captured with a 60x oil objective. Scale bars in left panels are 20 μm and scale bars in right panels (insets) are 5 μm. (E) GFP-LC3 synthesis with BafA1 in the presence of compound 31 (1 μM) or vehicle control. BafA1 was added for 1 hour during either the first hour of -aa starvation (“0-1 hr” bars) or after 4 hours of -aa starvation (“4-5 hr” bars). Data shown represent GFP-LC3 puncta synthesis relative to vehicle control. Symbols represent mean and bars are s.e.m. **** = adjusted p < 0.0001, one-way ANOVA.

    Journal: PLOS One

    Article Title: Quantitative and temporal analysis of autophagy: Differential Response to amino acid and glucose starvation

    doi: 10.1371/journal.pone.0340957

    Figure Lengend Snippet: (A) GFP-WIPI1 (green, left Y-axis) and GFP-WIPI2B (purple, right Y-axis) object counts over the 6 hour -aa treatment were overlaid. The gray region indicates the immediate starvation period (0-1 hours), and the yellow highlights the period of delayed autophagy under sustained starvation (3-6 hours). (B) EGFP-2xFYVE puncta (PI(3)P-positive cell membranes) were quantified from cells under FM (blue) or -aa (red) treatment. Note a lack of substantial puncta increase in the immediate (0-1 hour) period (gray shading). (C) The fraction of cells containing at least 1 GFP-WIPI2B puncta is plotted with time of -aa starvation. The dashed line represents 50% of the cell population. (D) Representative EGFP-2xFYVE puncta in U2OS cells treated with a VPS34 inhibitor (1 μM compound 31, lower panels) or vehicle control (upper panels). Blue = Hoechst nuclear stain; green = EGFP-2xFYVE; captured with a 60x oil objective. Scale bars in left panels are 20 μm and scale bars in right panels (insets) are 5 μm. (E) GFP-LC3 synthesis with BafA1 in the presence of compound 31 (1 μM) or vehicle control. BafA1 was added for 1 hour during either the first hour of -aa starvation (“0-1 hr” bars) or after 4 hours of -aa starvation (“4-5 hr” bars). Data shown represent GFP-LC3 puncta synthesis relative to vehicle control. Symbols represent mean and bars are s.e.m. **** = adjusted p < 0.0001, one-way ANOVA.

    Article Snippet: The human osteosarcoma cell line U2OS (HTB-96) was purchased from American Type Culture Collection, and cells maintained in RPMI-1640 medium (Gibco, 11-875-119) supplemented with 10% fetal bovine serum (Corning, 35–010-CV) and cultured at 37°C in a humidified atmosphere containing 5% CO 2 .

    Techniques: Control, Staining

    (A) Cells were cultured with or without amino acids for 6 hours prior to a restimulation phase of 60 min with FM (containing amino acids). (B-C) Representative images of GFP-DFCP1 (B) or GFP-WIPI2B (C) puncta in U2OS cells that were starved of amino acids for 6 hours and subject to aa-restimulation for 0 min (left), 10 min (middle) or 20 min (right). Insets show 2x magnification of indicated region to highlight disappearance of puncta. (D-G) DFCP1 (D) , WIPI2B (E) , WIPI1 (F) , and LC3B (G) quantified from cells during the restimulation period following -aa (red) or FM (blue) treatments. Symbols are mean GFP-positive puncta per cell and bars are s.e.m. Solid lines are non-linear regression models (one phase exponential decay). Gray shaded area emphasizes restoration to FM levels within 20 min of aa restimulation.

    Journal: PLOS One

    Article Title: Quantitative and temporal analysis of autophagy: Differential Response to amino acid and glucose starvation

    doi: 10.1371/journal.pone.0340957

    Figure Lengend Snippet: (A) Cells were cultured with or without amino acids for 6 hours prior to a restimulation phase of 60 min with FM (containing amino acids). (B-C) Representative images of GFP-DFCP1 (B) or GFP-WIPI2B (C) puncta in U2OS cells that were starved of amino acids for 6 hours and subject to aa-restimulation for 0 min (left), 10 min (middle) or 20 min (right). Insets show 2x magnification of indicated region to highlight disappearance of puncta. (D-G) DFCP1 (D) , WIPI2B (E) , WIPI1 (F) , and LC3B (G) quantified from cells during the restimulation period following -aa (red) or FM (blue) treatments. Symbols are mean GFP-positive puncta per cell and bars are s.e.m. Solid lines are non-linear regression models (one phase exponential decay). Gray shaded area emphasizes restoration to FM levels within 20 min of aa restimulation.

    Article Snippet: The human osteosarcoma cell line U2OS (HTB-96) was purchased from American Type Culture Collection, and cells maintained in RPMI-1640 medium (Gibco, 11-875-119) supplemented with 10% fetal bovine serum (Corning, 35–010-CV) and cultured at 37°C in a humidified atmosphere containing 5% CO 2 .

    Techniques: Cell Culture

    Acetylshikonin reduces osteosarcoma cell viability and increases membrane permeability. (A) Molecular structure of acetylshikonin. (B) CCK-8 assay results showing the viability of hFOB 1.19 cells following exposure to acetylshikonin (0.5–3 µM) for 24 h (n=4). (C) MG63, (D) HOS and (E) U2OS cell viability was assessed using the CCK-8 assay following treatment with acetylshikonin (0.05–20 µM) for 24 and 48 h (n=4). (F) Phase-contrast microscopy images depicting morphological changes in osteosarcoma cells treated with acetylshikonin (3 µM) for 24 h (n=4). (G) Fluorescence microscopy images showing nuclear staining with Hoechst 33342, membrane integrity with PI and viability with Calcein-AM in osteosarcoma cells treated with acetylshikonin (0.5–10 µM) for 24 h (n=4). Data are presented as the mean ± SD. *P<0.05 vs. untreated control. CCK-8, Cell Counting Kit-8; PI, propidium iodide.

    Journal: Molecular Medicine Reports

    Article Title: Acetylshikonin induces ferroptosis via the lipid peroxidation pathway in osteosarcoma cells

    doi: 10.3892/mmr.2025.13765

    Figure Lengend Snippet: Acetylshikonin reduces osteosarcoma cell viability and increases membrane permeability. (A) Molecular structure of acetylshikonin. (B) CCK-8 assay results showing the viability of hFOB 1.19 cells following exposure to acetylshikonin (0.5–3 µM) for 24 h (n=4). (C) MG63, (D) HOS and (E) U2OS cell viability was assessed using the CCK-8 assay following treatment with acetylshikonin (0.05–20 µM) for 24 and 48 h (n=4). (F) Phase-contrast microscopy images depicting morphological changes in osteosarcoma cells treated with acetylshikonin (3 µM) for 24 h (n=4). (G) Fluorescence microscopy images showing nuclear staining with Hoechst 33342, membrane integrity with PI and viability with Calcein-AM in osteosarcoma cells treated with acetylshikonin (0.5–10 µM) for 24 h (n=4). Data are presented as the mean ± SD. *P<0.05 vs. untreated control. CCK-8, Cell Counting Kit-8; PI, propidium iodide.

    Article Snippet: The human osteosarcoma cell lines (U2OS, HOS and MG63) and normal human osteoblasts (hFOB 1.19) were sourced from the American Type Culture Collection.

    Techniques: Membrane, Permeability, CCK-8 Assay, Microscopy, Fluorescence, Staining, Control, Cell Counting

    Acetylshikonin induces DNA fragmentation in osteosarcoma cells. Osteosarcoma cells (5×10 5 ) were treated with acetylshikonin (0.1–3 µM) for 24 h, then underwent the TUNEL assay. Fluorescence was analyzed by flow cytometry (n=4). Untreated cells were used as controls. Data are presented as the mean ± SD. *P<0.05, **P<0.01 vs. untreated control.

    Journal: Molecular Medicine Reports

    Article Title: Acetylshikonin induces ferroptosis via the lipid peroxidation pathway in osteosarcoma cells

    doi: 10.3892/mmr.2025.13765

    Figure Lengend Snippet: Acetylshikonin induces DNA fragmentation in osteosarcoma cells. Osteosarcoma cells (5×10 5 ) were treated with acetylshikonin (0.1–3 µM) for 24 h, then underwent the TUNEL assay. Fluorescence was analyzed by flow cytometry (n=4). Untreated cells were used as controls. Data are presented as the mean ± SD. *P<0.05, **P<0.01 vs. untreated control.

    Article Snippet: The human osteosarcoma cell lines (U2OS, HOS and MG63) and normal human osteoblasts (hFOB 1.19) were sourced from the American Type Culture Collection.

    Techniques: TUNEL Assay, Fluorescence, Flow Cytometry, Control

    Acetylshikonin induces apoptosis in osteosarcoma cells. Osteosarcoma cells (5×10 5 ) were treated with acetylshikonin (0.1–3 µM) for 24 h, then underwent the Annexin V/PI assay (n=4). Untreated cells were used as controls. Data are presented as the mean ± SD. *P<0.05 vs. untreated control. PI, propidium iodide.

    Journal: Molecular Medicine Reports

    Article Title: Acetylshikonin induces ferroptosis via the lipid peroxidation pathway in osteosarcoma cells

    doi: 10.3892/mmr.2025.13765

    Figure Lengend Snippet: Acetylshikonin induces apoptosis in osteosarcoma cells. Osteosarcoma cells (5×10 5 ) were treated with acetylshikonin (0.1–3 µM) for 24 h, then underwent the Annexin V/PI assay (n=4). Untreated cells were used as controls. Data are presented as the mean ± SD. *P<0.05 vs. untreated control. PI, propidium iodide.

    Article Snippet: The human osteosarcoma cell lines (U2OS, HOS and MG63) and normal human osteoblasts (hFOB 1.19) were sourced from the American Type Culture Collection.

    Techniques: Control

    Acetylshikonin promotes cell cycle arrest in osteosarcoma cells. Cell cycle distribution of osteosarcoma cells treated with acetylshikonin (0.1–3 µM) for 24 h, was assessed by propidium iodide staining and flow cytometry. Untreated cells were used as controls. Data are presented as the mean ± SD. *P<0.05 vs. untreated control.

    Journal: Molecular Medicine Reports

    Article Title: Acetylshikonin induces ferroptosis via the lipid peroxidation pathway in osteosarcoma cells

    doi: 10.3892/mmr.2025.13765

    Figure Lengend Snippet: Acetylshikonin promotes cell cycle arrest in osteosarcoma cells. Cell cycle distribution of osteosarcoma cells treated with acetylshikonin (0.1–3 µM) for 24 h, was assessed by propidium iodide staining and flow cytometry. Untreated cells were used as controls. Data are presented as the mean ± SD. *P<0.05 vs. untreated control.

    Article Snippet: The human osteosarcoma cell lines (U2OS, HOS and MG63) and normal human osteoblasts (hFOB 1.19) were sourced from the American Type Culture Collection.

    Techniques: Staining, Flow Cytometry, Control

    Acetylshikonin promotes intracellular ROS accumulation. Osteosarcoma cells (5×10 5 ) were treated with acetylshikonin (0.1–3 µM) for 1 h, then stained with 1 µM H 2 DCFDA. Fluorescence was analyzed by flow cytometry (n=4). Untreated cells served as controls. Data are presented as the mean ± SD. *P<0.05, **P<0.01 vs. untreated control. ROS, reactive oxygen species.

    Journal: Molecular Medicine Reports

    Article Title: Acetylshikonin induces ferroptosis via the lipid peroxidation pathway in osteosarcoma cells

    doi: 10.3892/mmr.2025.13765

    Figure Lengend Snippet: Acetylshikonin promotes intracellular ROS accumulation. Osteosarcoma cells (5×10 5 ) were treated with acetylshikonin (0.1–3 µM) for 1 h, then stained with 1 µM H 2 DCFDA. Fluorescence was analyzed by flow cytometry (n=4). Untreated cells served as controls. Data are presented as the mean ± SD. *P<0.05, **P<0.01 vs. untreated control. ROS, reactive oxygen species.

    Article Snippet: The human osteosarcoma cell lines (U2OS, HOS and MG63) and normal human osteoblasts (hFOB 1.19) were sourced from the American Type Culture Collection.

    Techniques: Staining, Fluorescence, Flow Cytometry, Control

    Acetylshikonin disrupts mitochondrial membrane potential. Cells were incubated with acetylshikonin (1 µM) for (A) 2 or (B) 8 h and subsequently stained with JC-1 (n=4). (C) Western blot analysis of Bcl-2, Bcl-xl, Bax and Bak protein expression in osteosarcoma cells following acetylshikonin treatment (0.1–3 µM) for 8 h (n=4). Untreated cells served as controls. Data are presented as the mean ± SD.

    Journal: Molecular Medicine Reports

    Article Title: Acetylshikonin induces ferroptosis via the lipid peroxidation pathway in osteosarcoma cells

    doi: 10.3892/mmr.2025.13765

    Figure Lengend Snippet: Acetylshikonin disrupts mitochondrial membrane potential. Cells were incubated with acetylshikonin (1 µM) for (A) 2 or (B) 8 h and subsequently stained with JC-1 (n=4). (C) Western blot analysis of Bcl-2, Bcl-xl, Bax and Bak protein expression in osteosarcoma cells following acetylshikonin treatment (0.1–3 µM) for 8 h (n=4). Untreated cells served as controls. Data are presented as the mean ± SD.

    Article Snippet: The human osteosarcoma cell lines (U2OS, HOS and MG63) and normal human osteoblasts (hFOB 1.19) were sourced from the American Type Culture Collection.

    Techniques: Membrane, Incubation, Staining, Western Blot, Expressing

    Acetylshikonin decreases mitochondrial volume and enhances lipid peroxidation in osteosarcoma cells. (A) Transmission electron microscopy images of HOS cells treated with acetylshikonin (3 µM) for 24 h, showing a reduction in mitochondrial volume (blue triangles). The red arrow indicates the endoplasmic reticulum. (B) Fluorescence microscopy analysis of lipid peroxidation in osteosarcoma cells treated with acetylshikonin (3 µM) and C11-BODIPY™ 581/591 (n=4). (C-E) Flow cytometric analyses showing lipid peroxidation in osteosarcoma cells incubated with acetylshikonin (0.1–3 µM) and C11-BODIPY (581/591) for 30 min (n=4). (F-H) Intracellular Fe 2+ levels in osteosarcoma cells treated with acetylshikonin (3 µM) for 24 h were quantified using an Fe 2+ detection reagent and microplate reader. (I-K) Western blot analysis of GPX4 protein expression in osteosarcoma cells treated with acetylshikonin (0.1–3 µM) for 8 h (n=4). Untreated cells served as controls. Data are presented as the mean ± SD. *P<0.05 vs. untreated control. GPX4, glutathione peroxidase 4; Fe 2+ , ferrous ion.

    Journal: Molecular Medicine Reports

    Article Title: Acetylshikonin induces ferroptosis via the lipid peroxidation pathway in osteosarcoma cells

    doi: 10.3892/mmr.2025.13765

    Figure Lengend Snippet: Acetylshikonin decreases mitochondrial volume and enhances lipid peroxidation in osteosarcoma cells. (A) Transmission electron microscopy images of HOS cells treated with acetylshikonin (3 µM) for 24 h, showing a reduction in mitochondrial volume (blue triangles). The red arrow indicates the endoplasmic reticulum. (B) Fluorescence microscopy analysis of lipid peroxidation in osteosarcoma cells treated with acetylshikonin (3 µM) and C11-BODIPY™ 581/591 (n=4). (C-E) Flow cytometric analyses showing lipid peroxidation in osteosarcoma cells incubated with acetylshikonin (0.1–3 µM) and C11-BODIPY (581/591) for 30 min (n=4). (F-H) Intracellular Fe 2+ levels in osteosarcoma cells treated with acetylshikonin (3 µM) for 24 h were quantified using an Fe 2+ detection reagent and microplate reader. (I-K) Western blot analysis of GPX4 protein expression in osteosarcoma cells treated with acetylshikonin (0.1–3 µM) for 8 h (n=4). Untreated cells served as controls. Data are presented as the mean ± SD. *P<0.05 vs. untreated control. GPX4, glutathione peroxidase 4; Fe 2+ , ferrous ion.

    Article Snippet: The human osteosarcoma cell lines (U2OS, HOS and MG63) and normal human osteoblasts (hFOB 1.19) were sourced from the American Type Culture Collection.

    Techniques: Transmission Assay, Electron Microscopy, Fluorescence, Microscopy, Incubation, Western Blot, Expressing, Control

    Acetylshikonin induces ferroptosis-mediated cell death. (A-C) CCK-8 assay results of osteosarcoma cells pretreated with ferrostatin-1 (10 µM), z-DEVD-FMK (10 µM), necrostatin-1 (10 µM), IM54 (10 µM) and liproxstain-1 (1 µM) for 1 h before exposure to acetylshikonin (3 µM) for 24 h (n=4). (D) Flow cytometric analysis of Annexin V/PI staining in osteosarcoma cells pretreated with ferrostatin-1 (10 µM) for 1 h followed by acetylshikonin (3 µM) for 24 h (n=4). (E) CCK-8 assay results of osteosarcoma cells treated with acetylshikonin (3 µM), erastin (3 µM) and RSL3 (3 µM) for 24 h (n=4). Untreated cells served as controls. Data are presented as the mean ± SD. *P<0.05 vs. untreated control; # P<0.05 vs. acetylshikonin-treated group. CCK-8, Cell Counting Kit-8.

    Journal: Molecular Medicine Reports

    Article Title: Acetylshikonin induces ferroptosis via the lipid peroxidation pathway in osteosarcoma cells

    doi: 10.3892/mmr.2025.13765

    Figure Lengend Snippet: Acetylshikonin induces ferroptosis-mediated cell death. (A-C) CCK-8 assay results of osteosarcoma cells pretreated with ferrostatin-1 (10 µM), z-DEVD-FMK (10 µM), necrostatin-1 (10 µM), IM54 (10 µM) and liproxstain-1 (1 µM) for 1 h before exposure to acetylshikonin (3 µM) for 24 h (n=4). (D) Flow cytometric analysis of Annexin V/PI staining in osteosarcoma cells pretreated with ferrostatin-1 (10 µM) for 1 h followed by acetylshikonin (3 µM) for 24 h (n=4). (E) CCK-8 assay results of osteosarcoma cells treated with acetylshikonin (3 µM), erastin (3 µM) and RSL3 (3 µM) for 24 h (n=4). Untreated cells served as controls. Data are presented as the mean ± SD. *P<0.05 vs. untreated control; # P<0.05 vs. acetylshikonin-treated group. CCK-8, Cell Counting Kit-8.

    Article Snippet: The human osteosarcoma cell lines (U2OS, HOS and MG63) and normal human osteoblasts (hFOB 1.19) were sourced from the American Type Culture Collection.

    Techniques: CCK-8 Assay, Staining, Control, Cell Counting